DistilINFO Originals
|
31
Jul
|
ER rush could be the thing of past: UnitedHealth CEOThe COVID-19 pandemic may result in a long-term decrease in-patient utilization of hospital emergency rooms. During a conference call with... Continue Reading
|
|
30
Jul
|
BCBS Massachusetts’ new collaboration to reduce vaccination disparitiesBlue Cross and Blue Shield of Massachusetts has launched a collaboration with Equity Now & Beyond, a collaborative of five immigrant-led... Continue Reading
|
|
29
Jul
|
No Surprises Act: The Long-Overdue Shield for PatientsUnexpected medical bills have been a major affordability concern for millions of American families for decades, so much so that... Continue Reading
|
|
29
Jul
|
Centene creates the Office of President to boost servicesIn order to better acknowledge the business’s size and scope, extend leaders’ skills, and support Centene’s ongoing development and innovation,... Continue Reading
|
|
29
Jul
|
BCBS of Kansas City files lawsuit against GS LabsBlue Cross and Blue Shield of Kansas City has sued a national COVID-19 testing facility, alleging GS Labs intentionally inflated... Continue Reading
|
|
28
Jul
|
New Announcement for Medicare insurers: OIGIn an advisory opinion earlier this month, the U.S. Department of Health and Human Services Office of the Inspector General... Continue Reading
|
|
28
Jul
|
New data reveal gouging of covid 19 test pricesThroughout the epidemic, health insurance companies have worked to ensure that patients have access to the COVID-19 tests they need.... Continue Reading
|
|
28
Jul
|
XSOLIS, Humana Collaborate for Enhanced UtilizationXSOLIS is a healthcare technology company that is developing an artificial intelligence-based network for payer-provider utilization management that is objective... Continue Reading
|
|
28
Jul
|
Sixth Street Growth Invests $50M for VisQuate’s GrowthVisiQuate, Inc., a Santa Rosa, CA-based provider of advanced analytics and AI-powered automation announced a new $50 million equity investment... Continue Reading
|
|
28
Jul
|
What does the Q2 report of Anthem say?Anthem delivered second-quarter 2021 earnings of $7.03 per share, which beat the Zacks Consensus Estimate of $6.34 by 10.9% owing... Continue Reading
|